Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Menzies AM, Yeh I, Botton T, Bastian BC, Scolyer RA, Long GV

Publication

Pigment cell & melanoma research

Publication ID (Profile URL)

https://researcherprofiles.org/profile/1192434

Publication Year

2015

PubMed ID

26072686

Publication Title

Menzies AM, Yeh I, Botton T, Bastian BC, Scolyer RA, Long GV. Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion. Pigment Cell Melanoma Res. 2015 Sep; 28(5):607-10.